Residual fatigue in Guillain-Barré syndrome is related to axonal loss

Neurology

Volumn 81, Issue 21, 2013, Pages 1827-1831

  Drenthen, Judith ^a,b   Jacobs, Bart C ^b,c   Maathuis, Ellen M ^a   Van Doorn, Pieter A ^b   Visser, Gerhard H ^a   Blok, Joleen H ^a  

^a Departments of Clinical Neurophysiology   (Netherlands)

^b Consortium of Healthy Ageing   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CMAP compound muscle action potential; FSS Fatigue Severity Scale; GBS Guillain Barr syndrome; HADS Hospital Anxiety and Depression Scale; IQR interquartile range; MRC Medical Research Council; MU motor unit; MUNE motor unit number estimation; MUP motor unit potential; NCS nerve conduction studies; ODSS overall disability sum score; SNAP sensory nerve action potential

Indexed keywords

ACTION POTENTIAL; ADOLESCENT; ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MALE; MIDDLE AGED; MOTOR NERVE CONDUCTION; MOTOR UNIT NUMBER ESTIMATION; NERVE FIBER; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC EXAMINATION; PERIPHERAL NERVE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SENSORY NERVE; THENAR; ULNAR NERVE; YOUNG ADULT;

ADULT; AGED; AXONS; ELECTROMYOGRAPHY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE, SKELETAL; NEURAL CONDUCTION; PERIPHERAL NERVES; SEVERITY OF ILLNESS INDEX;

EID: 84891925785     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436073.21406.e6     Document Type: Article

References (27)

1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7:939-950.
2. Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007;130: 2245-2257.
3. Merkies IS, Faber CG. Fatigue in immune-mediated neuropathies. Neuromuscul Disord 2012;22(suppl 3):S203-S207.
4. de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA. Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease. Cell Mol Life Sci 2010;67:701-713.
5. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 1999;53:1648-1654.
6. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007;62:571-579.
7. Garssen MP, van Doorn PA, Visser GH. Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome. J Neurol 2006;253:851-856.
8. Martinez-Figueroa A, Hansen S, Ballantyne JP. A quantitative electrophysiological study of acute idiopathic polyneuritis. J Neurol Neurosurg Psychiatry 1977;40:156-161.
9. van Koningsveld R, Schmitz PI, Meché FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet 2004;363:192-196.
10. van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992;326:1123-1129.
11. The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994;35:749-752.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
13. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;2:750-753.
14. Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72:596-601.
15. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14:1103-1109.
16. Krupp LB, LaRo vccxcca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
18. Drenthen J, Blok JH, van Heel EB, Visser GH. Limb temperature and nerve conduction velocity during warming with hot water blankets. J Clin Neurophysiol 2008;25: 104-110.
19. Buschbacher RM, Prahlow ND. Manual of Nerve Conduction Studies, 2nd ed. New York: DemosMedical Publishing; 2006.
20. McComas AJ, Fawcett PR, Campbell MJ, Sica RE. Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry 1971;34:121-131.
21. Shefner JM. Motor unit number estimation in human neurological diseases and animal models. Clin Neurophysiol 2001;112:955-964.
22. Slawnych M, Laszlo C, Hershler C. Motor unit number estimation: sample size considerations. Muscle Nerve 1997;20:22-28.
23. van Dijk JP, Zwarts MJ, Schelhaas HJ, Stegeman DF. Effect of small motor unit potentials on the motor unit number estimate. Muscle Nerve 2008;38:887-892.
24. Blok JH, Van Dijk JP, Zwarts MJ, Stegeman DF. Motor unit action potential topography and its use in motor unit number estimation. Muscle Nerve 2005;32:280-291.
25. Dornonville de la CourC, AndersenH, Stalberg E, Fuglsang-Frederiksen A, Jakobsen J. Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome. Muscle Nerve 2005;31:70-77.
26. Henneman E, Somjen G, Carpenter DO. Excitability and inhibitability of motoneurons of different sizes. J Neurophysiol 1965;28:599-620.
27. Gordon T, Thomas CK, Munson JB, Stein RB. The resilience of the size principle in the organization of motor unit properties in normal and reinnervated adult skeletal muscles. Can J Physiol Pharmacol 2004;82:645-661.